Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jay S Stout Insider Profile
4 Followers
Jay S Stout, SVP Tech. Op at Aravive, holds 142.19K shares in Immunovant (Ticker: IMVT), holds 185.65K shares in Aravive (Ticker: ARAV). Most recently, Jay S Stout Sold ― shares of Immunovant on Oct 25, 2024 for an estimated value of 80.91K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+7.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CTO
Roles that Jay S Stout holds in companies
Most Profitable Insider Trade
Stock:
Aravive
(ARAV)
(ARAV)
Rating:Informative Sell
Date:Apr 25, 2018 - Apr 25, 2019
Return:+38.20%
The most profitable trade made by Jay S Stout
Jay S Stout's Trading History
Aravive
Apr 25, 2018
―
Informative Sell
7.52K
$7.43K
Immunovant
Oct 25, 2024
CTO
Informative Sell
80.91K
$4.31M
List of latest transactions for each holding click on a transaction to see Jay S Stout's performance on stock
You May Also Like
Jay S Stout insider profile FAQ
What is the percentage of profitable transactions made by Jay S Stout?
The percentage of profitable transactions made by Jay S Stout is 50%.
What is the average return per transaction made by Jay S Stout?
The average return per transaction made by Jay S Stout is 7.90%.
What stocks does Jay S Stout hold?
Jay S Stout holds: ARAV, IMVT stocks.
What was Jay S Stout’s latest transaction?
Jay S Stout latest transaction was an Informative Sell of $80.91K.
What was Jay S Stout's most profitable transaction?
Jay S Stout’s most profitable transaction was an Informative Sell of ARAV stock on April 25, 2018. The return on the trade was 38.20%.
What is Jay S Stout's role in Aravive?
Jay S Stout's role in Aravive is SVP Tech. Op.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.